TickerFacts.

Intellia Therapeutics, Inc. (NTLA): Operating Income

Annual figures by period end, from SEC filings.

-$440.99M
Year ended 2025-12-31
-$423.48M
Trailing 12 months to 2026-06-30
2015-12-31: -$13.41M2016-12-31: -$32.16M2017-12-31: -$69.56M2018-12-31: -$90.87M2019-12-31: -$106.37M2020-12-31: -$136.58M2021-12-31: -$267.85M2022-12-31: -$458.16M2023-12-31: -$515.29M2024-12-31: -$534.26M2025-12-31: -$440.99M-$440.99M
2015-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$440.99Mn/m2026-02-26, From 2025-01-01
2024-12-31-$534.26Mn/m2026-02-26, From 2024-01-01
2023-12-31-$515.29Mn/m2026-02-26, From 2023-01-01
2022-12-31-$458.16Mn/m2025-02-27, From 2022-01-01
2021-12-31-$267.85Mn/m2024-02-22, From 2021-01-01
2020-12-31-$136.58Mn/m2023-02-23, From 2020-01-01
2019-12-31-$106.37Mn/m2022-02-24, From 2019-01-01
2018-12-31-$90.87Mn/m2021-02-26, From 2018-01-01
2017-12-31-$69.56Mn/m2020-02-27, From 2017-01-01
2016-12-31-$32.16Mn/m2019-02-27, From 2016-01-01
2015-12-31-$13.41Mn/a2018-03-14, From 2015-01-01

Operating Income at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$440.99Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$16.98Mn/m
Immucell Corp (ICCC)2025-12-31$1.65Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.91Mn/m
Anbio Biotechnology (NNNN)2025-12-31$5.77M+189.1%
Myriad Genetics Inc (MYGN)2025-12-31-$387.20Mn/m
Neogen Corp (NEOG)2026-05-31-$21.60Mn/m
Biomerica Inc (BMRA)2026-05-31-$5.32Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$51.12Mn/m

Compare NTLA, TKNO, ICCC, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗